1. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al. Sorafenib in advanced hepatocellular carcinoma. The New England journal of medicine. 2008; 359(4): 378-90. DOI: 10.1056/NEJMoa0708857. [
DOI:10.1056/NEJMoa0708857]
2. El-Serag HB. Hepatocellular carcinoma. The New England journal of medicine. 2011; 365(12): 1118-27. DOI: 10.1056/NEJMra1001683. [
DOI:10.1056/NEJMra1001683]
3. Marrero JA, Feng Z, Wang Y, Nguyen MH, Befeler AS, Roberts LR, et al. Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma. Gastroenterology. 2009; 137(1): 110-8. doi: 10.1053/j.gastro.2009.04.005. [
DOI:10.1053/j.gastro.2009.04.005]
4. McMichael AJ. Food, nutrition, physical activity and cancer prevention. Authoritative report from World Cancer Research Fund provides global update. Public health nutrition. 2008; 11(7): 762-3. [
DOI:10.1017/S1368980008002358]
5. Newman DJ, Cragg GM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. Journal of natural products. 2012; 75(3): 311-35. doi: 10.1021/np200906s. [
DOI:10.1021/np200906s]
6. Eddouks M, Lemhadri A, Michel JB. Caraway and caper: potential anti-hyperglycaemic plants in diabetic rats. Journal of ethnopharmacology. 2004; 94(1): 143-8. DOI: 10.1016/j.jep.2004.05.006. [
DOI:10.1016/j.jep.2004.05.006]
7. Jiang HE, Li X, Ferguson DK, Wang YF, Liu CJ, Li CS. The discovery of Capparis spinosa L. (Capparidaceae) in the Yanghai Tombs (2800 years b.p.), NW China, and its medicinal implications. Journal of ethnopharmacology. 2007; 113(3): 409-20. [
DOI:10.1016/j.jep.2007.06.020]
8. Kulisic-Bilusic T, Schmoller I, Schnabele K, Siracusa L, Ruberto G. The anticarcinogenic potential of essential oil and aqueous infusion from caper (Capparis spinosa L.). Food chemistry. 2012; 132(1): 261-7. doi: 10.1016/j.foodchem.2011.10.074. [
DOI:10.1016/j.foodchem.2011.10.074]
9. Eddouks M, Lemhadri A, Michel JB. Hypolipidemic activity of aqueous extract of Capparis spinosa L. in normal and diabetic rats. Journal of ethnopharmacology. 2005; 98(3): 345-50. [
DOI:10.1016/j.jep.2005.01.053]
10. Panico AM, Cardile V, Garufi F, Puglia C, Bonina F, Ronsisvalle G. Protective effect of Capparis spinosa on chondrocytes. Life sciences. 2005; 77(20): 2479-88. [
DOI:10.1016/j.lfs.2004.12.051]
11. Tabor E. Hepatocellular carcinoma: global epidemiology. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2001; 33(2): 115-7. [
DOI:10.1016/S1590-8658(01)80062-1]
12. Srivatanakul P, Sriplung H, Deerasamee S. Epidemiology of liver cancer: an overview. Asian Pacific journal of cancer prevention. APJCP. 2004; 5(2): 118-25.
13. Lam SK, Ng TB. A protein with antiproliferative, antifungal and HIV-1 reverse transcriptase inhibitory activities from caper (Capparis spinosa) seeds. Phytomedicine. international journal of phytotherapy and phytopharmacology. 2009; 16(5): 444-50. doi: 10.1016/j.phymed.2008.09.006. [
DOI:10.1016/j.phymed.2008.09.006]
14. Aghel N, Mombeini A. Hepatoprotective activity of Capparis spinosa root bark against ccl4 induced hepatic damage in mice. Iranian journal of pharmaceutical research : IJPR. 2007; 6(4): 285-290.
15. Sheikh M, Eshraghi HR, Khoshnia M, Mazandarani M, Moradi A. Cytotoxicity effect of Capparis spinosa L. on the HepG2 human hepatocellular carcinoma cell line. Indian J Tradit Knowle. 2017; 6(1): 230-8. رفرنس های متنی مثل خروجی کراس رف را در اینجا وارد کرده و تایید کنید